Clinical Trials Browser

Phase 2 × Completed × Diarrhea × Clear all

Diarrhea, Multiple Myeloma

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

NCT03722511 2022-11-03

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

Phase 2 Completed

10 enrolled

EndocrineNET

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

NCT00748215 2020-12-02

Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan

Phase 2 Completed

100 enrolled 17 charts

Gastrointestinal

Colonic Neoplasms, Diarrhea, Rectal Neoplasms, Colorectal Neoplasms

NCT00258180 2019-04-16

Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy

Phase 2 Completed

3 enrolled 5 charts

Diarrhea

NCT01543451 2014-03-26

Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea

Phase 2 Completed

138 enrolled

Diarrhea

Clinical Trials

A Study of Colesevelam for Lenalidomide-Associated Diarrhea

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan

Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy

Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea